Bleeding Risk of Tirofiban, a Nonpeptide GPIIb/IIIa Platelet Receptor Antagonist in Progressive Stroke: An Open Pilot Study

By  

Cerebrovascular Diseases, Vol. 12, Iss. 4, 2001-11 ,pp. : 308-312

Karger

Access to resources Recommend Favorite

Effect of Intravenous Tirofiban and Aspirin in Reducing Short-Term and Long-Term Neurologic Deficit in Patients with Ischemic Stroke: A Double-Blind Randomized Trial

By  

Cerebrovascular Diseases, Vol. 29, Iss. 3, 2010-01 ,pp. : 275-281

Karger

Access to resources Recommend Favorite

Selecting Patients for Early Stroke Treatment with Penumbra Images

By  

Cerebrovascular Diseases, Vol. 20, Iss. 2, 2005-12 ,pp. : 19-24

Karger

Access to resources Recommend Favorite

The Cologne Stroke Experience: Safety and Outcome in 450 Patients Treated with Intravenous Thrombolysis

By  

Cerebrovascular Diseases, Vol. 24, Iss. 1, 2007-05 ,pp. : 56-65

Karger

Access to resources Recommend Favorite

Efficacy of Thrombolytic (rt-PA) Therapy in Old Stroke Patients: The Perugia Stroke Unit Experience

By Parnetti Lucilla   Silvestrelli Giorgio   Lanari Alessia   Tambasco Nicola   Capocchi Giuseppe   Agnelli Giancarlo   Stroke Perugia  

Clinical and Experimental Hypertension, Vol. 28, Iss. 3-4, 2006-07 ,pp. : 397-404

Informa Healthcare

Access to resources Recommend Favorite